Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objectives: Development of the secondary to ACEI cough leads to discontinuation of the drugs of this group. Assessing the safety of the ACEIs with further development of customized approaches for their administration is a major scientific and practical problem. The objective of this study was to assess the association of the genetic markers with the development of the adverse drug reaction in the form of secondary to enalapril dry cough in the patients with essential arterial hypertension.
Methods: Study involved 113 patients with the secondary to enalapril cough and 104 patients without development of the secondary to enalapril adverse drug reaction.
Results: The patients carriers of the genotype AA rs2306283 of gene SLCO1B1 had 2-fold higher odds of developing the dry cough than those with the genotypes AG and GG (ОR=2.01, 95%CI=1.10-3.66, р=0.023). Similarly, the patients heterozygous for rs8176746 of gene АВО had 2.3-fold higher odds of developing the ADR in the form of dry cough than the carriers of the genotypes GG and TT (ОR=2.30, 95%CI=1.24-4.29, р=0.008).
Conclusions: Statistically significant association between the development of the ADR in the form of secondary to enalapril dry cough and polymorphisms rs2306283 of gene SLCO1B1 and rs8176746 of gene ABO was revealed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1515/dmpt-2023-0008 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Primary vesicoureteral reflux presenting as hypertensive crisis and thrombotic microangiopathy.
Hipertens Riesgo Vasc
August 2025
Paediatric Nephrology Department, Paediatric Clinical Management Unit, Regional University Hospital of Malaga, Malaga, Spain.
A 10-year-old boy with a history of febrile urinary tract infections presented with a hypertensive crisis and thrombotic microangiopathy (TMA). Functional and genetic complement testing was normal, and TMA resolved with blood pressure control, suggesting a primary hypertensive aetiology. Renal biopsy confirmed chronic tubulointerstitial nephritis (CTIN), likely secondary to recurrent pyelonephritis and renal scarring after ruling out other potential causes.
View Article and Find Full Text PDFEfficacy and safety of calcitriol therapy for reduction of proteinuria in children with chronic kidney disease: an open-label randomized controlled trial.
Int Urol Nephrol
June 2025
Division of Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi, India.
Purpose: Reducing proteinuria in children with chronic kidney disease (CKD) has been shown to slow the progression of kidney damage. Hence, we examined the efficacy of a combination of calcitriol and enalapril as compared to enalapril alone in reducing proteinuria in children with CKD.
Methods: Children aged 3 to 18 years with CKD and proteinuria > 250 mg/m/day were randomized to receive enalapril (0.
N-nitrosamines (NAs) are potentially carcinogenic organic compounds, and nitrosamine drug substance-related impurities (NDSRIs) are currently regulated with class-specific thresholds in the low nanogram range according to the carcinogenic potency categorization approach (CPCA) classification schema. Beyond direct exposure, NDSRIs can form endogenously in the human organism after ingestion of secondary amines. As recently shown, enalapril, propranolol, and fluoxetine form NDSRIs under conditions mimicking the acidic environment in the stomach.
View Article and Find Full Text PDFEfficacy and Safety of Enalapril and Propranolol on Neurologic Recovery After Isolated Severe Traumatic Brain Injury: A Randomized Clinical Trial.
World Neurosurg
July 2025
Isfahan University Students Research Committee (ISRC), Isfahan University of Medical Sciences, Isfahan, Iran.
Objective: It has been hypothesized that propranolol and enalapril can provide cardiovascular stability without any negative impact on neurologic recovery after severe traumatic brain injury (TBI). Although propranolol and enalapril have been proposed to have beneficial effects as cardiovascular stabilizers in TBI, many neurologic effects remain obscure. We hypothesized which of the following drugs could improve The Glasgow Outcome Scale-extended (GOS-E) in severe TBI patients.
View Article and Find Full Text PDFBackground: Women with heart failure (HF) ejection fraction appeared to respond more favorably to sacubitril/valsartan, compared with valsartan, than men in PARAGON-HF (Prospective Comparison of ARNI With ARB Global Outcomes in Heart Failure With Preserved Ejection Fraction), driven by a greater reduction in total (first and recurrent) HF hospitalizations. Sex-specific efficacy and safety of sacubitril/valsartan in PARADIGM-HF (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) remain unreported.
Methods And Results: This post hoc analysis of PARADIGM-HF examined sex-based outcomes in patients with HF and reduced ejection fraction randomized to sacubitril/valsartan or enalapril.